Funding know-how

Eureka Eurostars funds cross-border R&D projects led by innovative SMEs. Each partner is paid by its own national funding body, not by Eureka. Here is how eligibility, national funding rates, and Call 11 deadlines work in practice.

Kirill Rubinstein August 18, 2026 · 13 min read

A complete guide to the EU Innovation Fund: how relevant costs work, how GHG emission avoidance is calculated, which CAPEX band applies to your project, and whether the regular grant or auction route fits your situation best. Updated August 2026.

Aydan Aliyeva August 18, 2026 · 15 min read

The ZIM grant is the German federal government's largest funding programme for research and development in small and mid-size companies. Since 7 July 2026, the BMWE has accepted no new applications. This guide covers eligibility, funding rates, and what to do next.

Kirill Rubinstein August 16, 2026 · 13 min read

Success rates in the 2026 Horizon Europe Health call ranged from 3.4% to 20% by topic. Here is how the three pillars, six clusters and EUR 93.5 billion budget are structured, and where your project fits.

Kirill Rubinstein July 27, 2026 · 25 min read

Research Allowance for startups Germany: the complete guide to eligibility, application process, payout and combination with VC and grant funding.

Kirill Rubinstein July 10, 2026 · 10 min read

The BMF circular on the research allowance is the Federal Ministry of Finance's central guidance on the FZulG: eligible costs, time tracking, contract research, affiliated companies and the claim itself. What the circular says and what it means for your 2026 application.

Kirill Rubinstein July 06, 2026 · 5 min read

EU funding programmes at a glance: EIC Accelerator, Horizon Europe, Eurostars and the EU Innovation Fund compared. Which EU grants fit which company, how much they pay, and how to combine them with German instruments like the research allowance.

Kirill Rubinstein July 06, 2026 · 6 min read

How to account for Germany's research allowance: the allowance is credited against tax and is not taxable business income. How to book the claim, assessment and payout in the balance sheet and P&L, when it stays tax-free, and the usual entries.

Kirill Rubinstein July 06, 2026 · 5 min read

Contract research and the research allowance: the principal claims 70 percent of the fee as eligible cost (for financial years from 2025), and the contractor must be based in the EU or EEA. Requirements, contract design, a worked example and typical mistakes.

Kirill Rubinstein July 06, 2026 · 5 min read

The research allowance and EU state-aid law: when de-minimis actually applies (only to sole proprietors' own hours), what the exclusion of undertakings in difficulty means, and how to check both hurdles cleanly before you apply.

Kirill Rubinstein July 06, 2026 · 5 min read

The Research Allowance is a tax-based incentive under the Research Allowance Act (FZulG) – non-dilutive, with no repayment obligation, and predictable. In the corporate income tax return it is not assessed, but decided separately and subsequently offset or paid out.

Aydan Aliyeva June 12, 2026 · 10 min read

The Research Allowance payout in Germany works differently from a classic funding grant: no money flows directly into the account after project approval; instead, a tax offsetting mechanism with a genuine refund effect applies. How high the allowance is in 2026, when the tax office pays out, and how to avoid common mistakes.

Kirill Rubinstein June 12, 2026 · 11 min read

The Research Allowance is the central instrument of tax-based research funding in Germany. For SMEs, an increased funding rate of 35 percent has applied since March 2024 on an assessment base of up to €12 million per financial year—that is up to €4.2 million in funding annually. Concrete real-world examples show the basic principle: no dilution, no repayment, a direct liquidity effect.

Kirill Rubinstein June 08, 2026 · 10 min read

The ZIM vs. Research Allowance comparison determines, for SMEs, liquidity, the effective tax rate, and the financeability of entire development portfolios. This article contrasts the funding requirements, funding amounts, application effort, and tax treatment of both programs and shows which instrument suits which company in 2026.

Aydan Aliyeva June 05, 2026 · 12 min read

How to claim the German Research Allowance (Forschungszulage) retroactively for completed fiscal years. Deadlines, eligibility, the step-by-step BSFZ and tax office process, and common errors for SMEs in 2026.

Aydan Aliyeva May 01, 2026 · 10 min read

Germany offers one of the densest funding systems worldwide in 2026, with federal, state and EU bodies providing several hundred billion Euro. This guide shows which programmes are relevant for whom – and where the Research Allowance gives SMEs the strongest, non-dilutive lever.

Kirill Rubinstein April 20, 2026 · 12 min read

Subsidy examples in Germany range from building renovation support and agricultural diesel relief to R&D tax incentives. For founders, CFOs and R&D managers, what matters is not the largest subsidy but the most accessible one – which determines the real liquidity effect.

Kirill Rubinstein April 20, 2026 · 10 min read

Startup financing in Germany goes far beyond equity, bank loans and grants. This guide shows how founders can combine equity, debt, government programmes and the non-dilutive Research Allowance into a smart financing architecture.

Kirill Rubinstein April 12, 2026 · 11 min read

The R&D tax allowance (Forschungszulage) has been Germany's central R&D funding instrument since 2020 and is now significantly more attractive. This guide shows how the two-stage application process via BSFZ and Mein ELSTER works in practice in 2026.

Kirill Rubinstein April 11, 2026 · 9 min read

BSFZ Germany is the operational gateway to R&D tax incentives: the Certification Body for Research Allowance certifies the technical R&D quality of a project before the tax office assesses the allowance. For SMEs, the 2026 framework means 35% on the eligible assessment basis as predictable, non-dilutive liquidity.

Kirill Rubinstein April 11, 2026 · 12 min read

The FZulG (Research Allowance Act) is Germany's strongest non-dilutive R&D funding instrument: 35 percent for SMEs, an assessment basis of up to 12 million Euro and payout even during losses. This guide covers eligibility, eligible costs, the BSFZ application process and the 2026 legal position.

Kirill Rubinstein April 11, 2026 · 11 min read

Non-repayable grants in Germany are earmarked funding that neither needs to be repaid nor bears interest. For founders, the self-employed and growing SMEs they are the most efficient financing instrument – provided one knows the right programmes, requirements and pitfalls.

Kirill Rubinstein April 11, 2026 · 11 min read

The Research Allowance Act (FZulG) gives R&D-active SMEs in Germany a predictable, non-dilutive funding channel: 35 percent for SMEs, a broad cost base and, from 2026, an assessment basis of up to 12 million Euro per fiscal year. This guide explains eligibility, calculation, the two-stage BSFZ and tax office process and the most common reasons for rejection.

Kirill Rubinstein April 11, 2026 · 11 min read

A subsidy is a government advantage without a market-equivalent consideration in return, granted as financial aid, tax incentives or product subsidies. This article defines subsidies, explains the main types in Germany, who funds and receives them, what is most heavily subsidised, and how instruments like the Research Allowance fit a company's investment logic.

Kirill Rubinstein April 11, 2026 · 9 min read

The Research Allowance is for many SMEs in 2026 the most predictable non-dilutive R&D building block. Since March 2024 the SME rate is 35 %, and with an assessment basis of up to 12 million Euro, up to 4.2 million Euro is achievable. This guide covers rates, eligible activities and the two-stage application process.

Kirill Rubinstein April 10, 2026 · 10 min read